AARD vs ILMN · $284.4M cap vs rev $2.25B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
AARD currently screens at market cap $284.4M. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the AARD and ILMN stock pages for the full models.
Not investment advice.